The Valley Desk

NCT04590326 · Interventional trial

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov